Finance Your Medical Billing Company Acquisition with an SBA Loan
SBA 7(a) loans cover up to 90% of the purchase price for qualified RCM business acquisitions — giving you the leverage to buy a recurring-revenue healthcare services business with as little as 10% down.
Find SBA-Eligible Medical Billing Company BusinessesSBA Overview for Medical Billing Company Acquisitions
Medical billing and revenue cycle management companies are strong candidates for SBA 7(a) acquisition financing. These businesses generate stable, recurring fee-based revenue from physician practices, hospital groups, and specialty clinics — revenue that lenders view favorably because it is contractually driven and non-discretionary. The U.S. Small Business Administration's 7(a) loan program allows qualified buyers to finance up to 90% of the acquisition price, typically up to $5 million, with repayment terms of 10 years for business acquisitions. For a medical billing company generating $1M–$5M in annual revenue with $500K or more in EBITDA, SBA financing can make the acquisition achievable for individual operators or small strategic acquirers who cannot fund the full purchase price from cash reserves. Because medical billing companies are service businesses with minimal hard assets, lenders rely heavily on historical cash flow, client contract quality, and compliance history to underwrite the loan — making thorough deal preparation essential before approaching an SBA lender.
Down payment: Most SBA lenders require a minimum 10% buyer equity injection for medical billing company acquisitions, meaning a $3M purchase price requires at least $300,000 in cash from the buyer. However, because medical billing companies are intangible-asset-heavy service businesses with limited collateral, many lenders will require 15–20% down to offset the absence of hard assets that would otherwise secure the loan. If the seller agrees to carry a seller note — typically 10–15% of the purchase price on full standby for 24 months — lenders may accept this as partial equity, effectively reducing the cash the buyer must inject at close. Buyers should expect to document the source of their down payment funds through 3–6 months of bank statements and be prepared to demonstrate additional liquidity reserves to cover post-close working capital needs, particularly during any client transition period.
SBA Loan Options
SBA 7(a) Standard Loan
10-year repayment for business acquisitions; fixed or variable interest rates currently ranging from 10.5%–13.5% depending on loan size and lender; fully amortizing with no balloon payment
$5,000,000
Best for: Full acquisitions of established medical billing companies with $1M–$5M in revenue, covering purchase price, working capital, and transaction costs in a single loan facility
SBA 7(a) Small Loan
10-year repayment with streamlined underwriting; slightly higher interest rates than standard 7(a); faster approval timelines through SBA Preferred Lenders
$500,000
Best for: Smaller RCM company acquisitions or add-on acquisitions of niche billing practices serving a single specialty such as behavioral health or physical therapy
SBA 504 Loan
10- or 20-year fixed-rate debenture on CDC portion; bank first mortgage at market rates; CDC portion fixed below market
$5,500,000 combined (CDC + bank)
Best for: Acquisitions that include significant real estate or major equipment purchases alongside the business — less commonly used for pure medical billing service company acquisitions with minimal hard assets
Eligibility Requirements
- The business must be a for-profit U.S.-based operation with annual revenue under $15 million and operating as an independent medical billing or RCM services company — not a captive billing division of a larger health system
- The buyer must inject a minimum 10% equity down payment from verifiable personal or business funds, not borrowed capital, and demonstrate sufficient liquidity post-close to support working capital needs
- The target company must demonstrate at least 2–3 years of positive cash flow, typically $500K or more in EBITDA, with documented financial statements prepared or reviewed by a licensed CPA
- Client revenue must be verifiable through signed contracts, remittance data, and practice management system reports — lenders will require proof of recurring revenue stability and will scrutinize client concentration risk
- The acquisition must pass a business valuation ordered by the lender, typically conducted by a certified business appraiser, confirming the purchase price is supported by the company's earnings and market multiples of 3.5x–6x EBITDA
- The buyer must have relevant industry experience in healthcare administration, revenue cycle management, or medical billing operations, or must demonstrate a management plan that addresses post-acquisition operational continuity
Step-by-Step Process
Identify and Qualify a Target Medical Billing Company
Source acquisition candidates through healthcare-focused business brokers, RCM industry networks, or direct outreach to owner-operators. Prioritize targets with minimum $500K EBITDA, diversified client bases across multiple specialties, documented client contracts, and clean HIPAA compliance history. Request a 3-year P&L, aging accounts receivable summary, and a client roster with revenue concentration data before signing an LOI.
Engage an SBA-Experienced Lender Early
Contact SBA Preferred Lenders or Certified Development Companies with demonstrated experience financing healthcare services acquisitions. Share your target company's financial summary and business overview to get a preliminary read on loan sizing and structure before executing a letter of intent. Lenders experienced in RCM acquisitions will understand percentage-of-collections revenue models and recurring contract structures — reducing underwriting friction.
Execute a Letter of Intent and Order a Business Valuation
Once aligned on price and structure, execute a signed LOI that includes a 30–60 day exclusivity period. Your lender will order an independent business valuation from a certified appraiser, typically costing $3,000–$7,000, to confirm the purchase price is supported by the company's historical earnings and comparable RCM transaction multiples of 3.5x–6x EBITDA. The valuation must support the loan amount before underwriting proceeds.
Complete SBA Loan Application and Underwriting
Submit the formal SBA 7(a) loan application package including 3 years of business tax returns, 3 years of CPA-prepared financial statements, interim financials, a buyer personal financial statement, personal tax returns, a business plan with industry-specific projections, and evidence of client contracts and retention history. Underwriters will pay close attention to client concentration, HIPAA compliance documentation, and denial management performance metrics as proxies for revenue quality.
Conduct Full Due Diligence in Parallel
While underwriting proceeds, complete comprehensive due diligence on the target. Engage a healthcare attorney to review all client Business Associate Agreements, client contracts, payer enrollment records, and any history of OIG audits or compliance issues. Have a healthcare IT specialist assess the billing software stack, EHR integration agreements, and cybersecurity posture. Verify coder certifications (CPC, CCS) and assess key-person risk across the billing and account management team.
Receive Loan Commitment and Finalize Deal Structure
Upon credit approval, the lender issues a commitment letter outlining loan amount, rate, terms, and conditions. Finalize the purchase agreement with your attorney, incorporating any earnout provisions tied to client retention, seller note terms, and representations and warranties around HIPAA compliance and client contract continuity. Confirm that the seller will execute transition support agreements covering at minimum 6–12 months post-close.
Close the Loan and Complete the Acquisition
Coordinate closing between your attorney, lender, and the seller's advisors. SBA loans require all loan documents to be executed simultaneously with the purchase agreement. Funds are disbursed directly to the seller at close. Notify clients of the ownership transition according to the plan agreed upon with the seller, prioritizing personal introductions for top accounts to minimize churn risk during the critical first 90 days post-acquisition.
Common Mistakes
- ✗Underestimating client concentration risk: Buyers often focus on total EBITDA without stress-testing what happens if the top one or two medical practices — which may represent 30–40% of revenue — terminate their contracts post-acquisition. Lenders will haircut revenue projections for concentrated books, and so should you during valuation.
- ✗Ignoring HIPAA compliance gaps during due diligence: Informal billing practices, missing Business Associate Agreements, or undocumented security risk assessments can surface as material liabilities post-close. SBA lenders financing healthcare services acquisitions increasingly require representations around HIPAA compliance, and undisclosed violations can trigger indemnification claims or regulatory penalties.
- ✗Failing to secure seller transition support in the purchase agreement: Owner-operators in medical billing businesses often hold all key client relationships personally. Without a structured 6–12 month transition agreement that keeps the seller engaged in client introductions and relationship handoffs, revenue attrition in the first year can erode the earnings that justified the purchase price and debt service coverage.
- ✗Approaching generic SBA lenders unfamiliar with service business underwriting: Banks without healthcare services experience may apply hard-asset collateral requirements inappropriate for intangible-heavy medical billing companies, inflating down payment demands or declining otherwise creditworthy deals. Work exclusively with SBA Preferred Lenders who have closed comparable RCM or healthcare services acquisitions.
- ✗Overlooking technology obsolescence costs in financial projections: Legacy billing software without active vendor support or modern EHR integrations is a capital expenditure liability that buyers routinely exclude from post-acquisition financial models. Factor in the cost of software migration, new integration builds, and potential staff retraining when modeling debt service coverage — a $150K–$400K technology upgrade can materially impact year-one cash flow.
Lender Tips
- Present client contract documentation upfront: SBA underwriters financing medical billing acquisitions want to see executed client agreements, fee structures, renewal terms, and termination notice periods before issuing a term sheet. Organizing this package in advance signals deal quality and accelerates underwriting timelines significantly.
- Quantify recurring revenue clearly and separately from one-time billings: Build a revenue bridge that distinguishes ongoing percentage-of-collections or flat-fee contract revenue from project-based or one-time billing engagements. Lenders apply higher confidence multiples to demonstrably recurring revenue streams, which directly impacts the loan amount they will support.
- Provide collection rate benchmarks by specialty: Net collection rates of 95% or higher across the client base are a strong underwriting signal for RCM businesses. Presenting denial rate trends, days-in-AR metrics, and specialty-specific performance data demonstrates operational health and reduces lender risk perception beyond what financial statements alone convey.
- Secure a seller note with full standby provisions: Structuring 10–15% of the purchase price as a seller note on full standby for 24 months satisfies SBA equity injection requirements while reducing the buyer's cash outlay at close. Lenders view seller financing as a confidence signal — sellers who accept deferred payment have skin in the game and incentive to ensure a smooth transition.
- Commission a quality of earnings report for deals above $2M: For acquisitions in the $2M–$5M range, engaging a CPA firm to conduct a quality of earnings analysis — adjusting reported EBITDA for owner compensation normalization, one-time expenses, and client-level revenue sustainability — gives lenders an independent third-party validation of cash flow that meaningfully improves underwriting confidence and loan approval odds.
Find SBA-Ready Medical Billing Company Businesses
Pre-screened acquisition targets with verified financials — free to join.
SBA Loan Calculator
Estimate your monthly payment for a Medical Billing Company acquisition
Standard for acquisitions
Powered by Deal Flow OS
dealflow-os.com · Free M&A tools for every stage of the deal
Frequently Asked Questions
Can I use an SBA loan to buy a medical billing company with no prior healthcare experience?
SBA lenders will scrutinize management capability closely for healthcare services acquisitions. While prior medical billing experience is not strictly required, you will need to demonstrate relevant healthcare administration, operations management, or financial services background, and present a credible plan for retaining key billing staff and managers post-acquisition. Hiring an experienced RCM operations manager before close can substantially strengthen your loan application if your direct industry experience is limited.
How do lenders value a medical billing company for SBA loan purposes?
Lenders rely on an independent business valuation ordered as part of the SBA underwriting process. Valuations for medical billing companies are primarily earnings-based, applying a multiple to Seller's Discretionary Earnings or EBITDA. Current market multiples range from 3.5x to 6x EBITDA depending on client diversification, contract quality, collection rate performance, and technology infrastructure. The appraised value must support the proposed purchase price for the loan to proceed.
What documentation does an SBA lender need for a medical billing acquisition?
Expect to provide three years of business tax returns and CPA-prepared financial statements for the target company, interim year-to-date financials, a complete client revenue breakdown by account, executed client contracts, a buyer personal financial statement and three years of personal tax returns, a business plan with post-acquisition financial projections, and documentation of HIPAA compliance including signed Business Associate Agreements. Lenders may also request proof of coder certifications and key employee agreements.
How does client concentration affect SBA loan approval for a medical billing company?
Client concentration is one of the most common underwriting concerns for medical billing acquisitions. If one or two practices represent more than 30% of total revenue, lenders will typically stress-test cash flow projections by modeling the loss of that revenue and assessing whether the remaining business can still service the debt. High concentration may require a larger down payment, a partial earnout structure tying a portion of the purchase price to client retention, or a seller note that remains at risk if key clients depart post-close.
Can earnout provisions be included in an SBA-financed medical billing acquisition?
Yes. Earnout structures are common in medical billing acquisitions because they align seller incentives with client retention outcomes. SBA guidelines permit contingent earnout payments as part of the total deal consideration, provided the earnout is documented in the purchase agreement and the total acquisition cost including earnout remains within SBA size and eligibility parameters. Earnouts of 15–25% of purchase price tied to 12–24 month revenue or client retention thresholds are typical structures lenders will accept.
What are the typical SBA loan terms for a medical billing company acquisition?
SBA 7(a) loans for business acquisitions carry a 10-year repayment term with fully amortizing monthly payments. Interest rates are variable or fixed and currently range from approximately 10.5% to 13.5% depending on loan size, lender, and market conditions. There is no balloon payment, which improves cash flow predictability during the post-acquisition transition period. Loan amounts up to $5 million are available, covering purchase price, working capital, and eligible transaction costs.
Is a seller note required in an SBA-financed medical billing acquisition?
A seller note is not always required but is strongly encouraged when the business has limited hard assets to pledge as collateral, which is typical for medical billing companies. SBA lenders often view a seller note of 10–15% on full standby for 24 months as partial equity injection, which can reduce the cash you need to bring to closing. It also signals that the seller is confident enough in the business's continued performance to accept deferred payment.
More Medical Billing Company Guides
More SBA Loan Guides
Start Finding Medical Billing Company Deals Today — Free to Join
Find SBA-eligible targets, score seller motivation, and get AI-written outreach in one platform.
Create your free accountNo credit card required